ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 761

$630K Total Retail Price of All Prescriptions

Rank: 62 out of 761

690 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 11,896 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 844 751 1 2
HYDROCODONE-ACETAMINOPHEN 538 403 S3 2 5
OMEPRAZOLE 522 455 3 4
AMLODIPINE BESYLATE 483 445 4 6
LISINOPRIL 450 386 5 1
LEVOTHYROXINE SODIUM 442 418 6 3
ATENOLOL 404 382 7 8
FUROSEMIDE 335 321 8 7
LOSARTAN POTASSIUM 330 312 9 13
METFORMIN HCL 312 244 10 10
WARFARIN SODIUM 277 268 11 9
METOPROLOL SUCCINATE 255 237 12 16
SERTRALINE HCL 229 194 13 25
ZOLPIDEM TARTRATE 212 178 14 22
HYDROCHLOROTHIAZIDE 210 200 15 11
ATORVASTATIN CALCIUM 187 166 16 12
TAMSULOSIN HCL 185 169 17 27
POTASSIUM CHLORIDE 177 160 18 18
DONEPEZIL HCL 167 167 19 33
GLIMEPIRIDE 156 137 20 48
PAROXETINE HCL 140 102 21 47
ALENDRONATE SODIUM 139 127 22 21
METOPROLOL TARTRATE 137 125 23 14
CRESTOR 135 127 24 36
TRAZODONE HCL 126 116 25 23
GABAPENTIN 116 97 26 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 105 27 35
TRAMADOL HCL 110 104 28 34
ALLOPURINOL 110 103 28 28
CLOPIDOGREL 109 108 30 66
POLYETHYLENE GLYCOL 3350 106 95 31 62
KLOR-CON 10 102 100 32 74
LOVASTATIN 101 93 33 17
CITALOPRAM HBR 92 83 34 19
FLUTICASONE PROPIONATE 88 77 35 29
DIGOXIN 84 81 36 43
PLAVIX 84 83 36 119
OXYCODONE HCL 82 14 S2 38 24
MORPHINE SULFATE ER 81 22 S2 39 38
PREDNISONE 80 75 40 30
TRIAMTERENE-HCTZ 76 71 41 42
NAMENDA 74 74 42 59
AMITRIPTYLINE HCL 72 54 R 43 54
TRIAMCINOLONE ACETONIDE 68 59 44 84
ADVAIR DISKUS 67 57 45 37
IBUPROFEN 66 50 46 103
CIPROFLOXACIN HCL 65 62 47 63
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 48 65
LYRICA 63 43 48 134
METHADONE HCL 61 14 S2 50 75
NEXIUM 58 47 51 98
BENICAR 57 57 52 81
DOXAZOSIN MESYLATE 57 55 52 55
CYMBALTA 57 37 52 53
NIFEDIPINE ER 57 50 52 128
LEVETIRACETAM 55 35 56 143
QUETIAPINE FUMARATE 54 24 57 90
DILTIAZEM 24HR CD 54 54 57 132
FENTANYL 53 26 S2 59 57
LANTUS 52 38 60 41
OXYCODONE-ACETAMINOPHEN 52 23 S2 60 49
HYDRALAZINE HCL 52 52 60 114
FLUOXETINE HCL 52 43 60 31
DIPHENOXYLATE-ATROPINE 52 50 60 242
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.